IndraLab

Statements


BRPF1 inhibits USP35. 1 / 1
| 1

reach
"We generated the C4-2b-derived tumor model and found that targeting BRPF1 could significantly suppress USP35 in vivo PRAD growth, as shown by tumor volumes and weight (Fig. 6F–H)."